Thyroid Disease Serum Repository

Thyroid Disease Clinical Trial

Official title:

Thyroid Disease Serum Repository

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00592605
• Other study ID #: 84287
• Status: Completed
• Phase: N/A
• First received: December 27, 2007
• Last updated: June 1, 2017
• Start date: May 2007
• Est. completion date: June 1, 2017

Study information

• Verified date: June 2017
• Source: University of Arkansas
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Thyroid disease is more common among females and is increasing in incidence.

Otolaryngology faculty members and residents will perform head and neck examinations as part of the subject's routine care. If the participant is noted to have thyroid disease, they will be asked if they would like to participate in the research portion by having approximately 10cc's of blood drawn. Faculty and staff will complete a data collection sheet that will contain demographic and clinical data.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: June 1, 2017
• Est. primary completion date: June 1, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participants with benign or malignant thyroid disease.

Related Conditions & MeSH terms

• Thyroid Disease
• Thyroid Diseases

Locations

Country	Name	City	State
United States	University of Arkansas for Medical Sciences	Little Rock	Arkansas

Sponsors (1)

Lead Sponsor	Collaborator
University of Arkansas

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To gather demographic and cultural information on approximately 1000 men and women with thyroid disease between the years 2007 and 2012 at the University of Arkansas for Medical Sciences.		2007-2012